Steve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Oppenheimer analyst Chris Kotowski on Monday reiterated an outperform rating on JPMorgan Chase & Co. and increased his price target on the stock to $233 from $215 after the bank’s stronger-than-expected third-quarter profit update.
“We view JPM as the country’s premier banking franchise with strengths across the board in consumer, commercial and institutional banking as well as asset management,” Kotowski said. Another plus at JPMorgan Chase is its credit quality, which “remains pretty stable at outstanding levels” although some normalizing is taking place, Kotowski said.
As for Wells Fargo, the bank posted stronger-than-expected net interest income and trading results, Kotowski said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Banks beat expectations but some economic cracks form as caution aboundsSteve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Read more »
Consolidated Communications Holdings to be acquired by two private-equity firmsSteve Gelsi covers banking and cannabis as a Senior Reporter for MarketWatch.
Read more »
In Study, Diabetes Drug Mounjaro Helped Dieters Shed an Average of 60 PoundsMONDAY, Oct. 16, 2023 (HealthDay News) -- A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds.
Read more »
Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds, study finds9NEWS' Anusha Roy talked to an expert about how obesity should be viewed.
Read more »